Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 272 of the 272 references it cites were found in a registry or an index.

Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology

Open access

Abstract

These British Association for Psychopharmacology guidelines cover the range and aims of treatment for anxiety disorders. They are based explicitly on the available evidence and are presented as recommendations to aid clinical decision making in primary and secondary medical care. They may also serve as a source of information for patients and their carers. The recommendations are presented together with a more detailed review of the available evidence. A consensus meeting involving experts in anxiety disorders reviewed the main subject areas and considered the strength of evidence and its clinical implications. The guidelines were constructed after extensive feedback from participants and interested parties. The strength of supporting evidence for recommendations was rated. The guidelines cover the diagnosis of anxiety disorders and key steps in clinical management, including acute treatment, relapse prevention and approaches for patients who do not respond to first-line treatments.

Overview

Integrity signals

Registry

Crossref · 10.1177/0269881105059253

Cites

272 of 272 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Show all 272 references

Research works printed but not linked: 41

  1. Allgulander C, ADAA meeting
  2. 10.1177/026988110001400101 · DOI · Paper page
  3. Baldwin D S, 1998, J Clin Psychiatry, 59, S39
  4. Ballenger J C, 1998, J Clin Psychiatry, 59, 47
  5. Ballenger J C, 1998, J Clin Psychiatry, 59, 54
  6. Ballenger J C, 2001, J Clin Psychiatry, 62, 53
  7. Ballenger J C, 2004, J Clin Psychiatry, 65, 55
  8. Bielski R J, 42nd Annual Meeting of the American College of Neuropsychopharmacology
  9. Bower P, 2001, Br J Gen Pract, 51, 838
  10. Committee on Safety of Medicines, 2004, Safety of selective serotonin reuptake inhibitor antidepressants
  11. Davidson J R, American College of Neuropsychopharmacology
  12. Den Boer J A, 1998, J Clin Psychiatry, 59, 30
  13. Dowell A C, 1990, Br J Gen Pract, 40, 27
  14. Durham R C, Long-term outcome of cognitive behavior therapy clinical trials in central Scotland
  15. Friedman M J, 2000, Effective Treatments for PTSD: Practice Guidelines from the International Society for Stress Studies, 84
  16. Gelpin E, 1996, J Clin Psychiatry, 57, 390
  17. Goldberg D, 1987, J R Coll Gen Pract, 37, 15
  18. Jorm A F, 2004, Med J Aust, 181, S29
  19. 10.1037/0022-006X.62.4.865 · DOI · Paper page
  20. 10.1002/(SICI)1520-6394(1999)10:3<89::AID-DA1>3.0.CO;2-5 · doi:10.1002/(sici)1520-6394(1999)10:3<89::aid-da1>3.0.co;2-5
  21. Meibach R C, 1987, J Clin Psychiatry, 84, 355
  22. Mendels J, 1986, J Clin Psychiatry, 47, 170
  23. National Institute for Clinical Excellence, 2004, Depression. Management of depression in primary and secondary care
  24. National Institute for Clinical Excellence, 2005, Post-traumatic stress disorder. The management of PTSD in adults and children in primary and secondary care
  25. Parkerson G R Jr, 1997, Fam Med, 29, 177
  26. Pollack M H, American College of Neuropsychopharmacology
  27. Pollack M H, 1994, J Clin Psychiatry, 55, 200
  28. Power K G, 1990, Br J Gen Pract, 40, 289
  29. 10.1034/j.1600-0447.2001.00263.x · DOI · Paper page
  30. Rasmussen S A, 1990, J Clin Psychiatry, 51, 10
  31. Royal College of Psychiatrists, 2005, Benzodiazepines: risks, benefits or dependence. A re-evaluation
  32. Sasson Y, 1997, J Clin Psychiatry, 58, 7
  33. Schatzberg A F, 1997, J Clin Psychiatry, 58, 5
  34. Stein D J, 2004, Cochrane Library
  35. Tollefson G D, 1994, J Clin Psychiatry, 55, 69
  36. 10.1002/(SICI)1099-0879(199809)5:3<126::AID-CPP153>3.0.CO;2-H · doi:10.1002/(sici)1099-0879(199809)5:3<126::aid-cpp153>3.0.co;2-h
  37. Weissman M M, 1994, J Clin Psychiatry, 55, 5
  38. Wheadon D, Annual Meeting of the American College of Neuro psychopharmacology
  39. Wittchen H U, 2002, J Clin Psychiatry, 63, 24
  40. World Health Organization, 1992, The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines
  41. World Health Organization, 2004, WHO Guide to Mental and Neurological Health in Primary Care

Cited by

See all 617

Metadata

Authors
Baldwin, D. S., Anderson, I. M., Nutt, D. J., Bandelow, B., Bond, A., Davidson, J. R. T., den Boer, J. A., Fineberg, N. A., Knapp, M., Scott, J., & Wittchen, H. U.
Affiliations
  • University of Southampton (GB)
  • University of Manchester (GB)
  • University of Bristol (GB)
  • University of Göttingen (DE)
  • King's College London (GB)
  • Duke Medical Center (US)
  • School of Behavioral and Cognitive Neurosciences, University Medical Center Groningen, Groningen, the Netherlands
  • University of Hertfordshire (GB)
  • Technical University of Dresden and Max Planck Institute of Psychiatry, Munich, Germany
Corresponding author
Baldwin, David S.
Venue
Journal of Psychopharmacology
Published
2005-11
Volume
19
Issue
6
Pages
567-596
ISSN
  • 0269-8811 (ISSN-L)
  • 1461-7285
OpenAlex
W2151852296
Cited by
617
References
272
Citations by year
2026: 7 · 2025: 8 · 2024: 13 · 2023: 6 · 2022: 9 · 2021: 21 · 2020: 22 · 2019: 22 · 2018: 26 · 2017: 24 · 2016: 22 · 2015: 29 · 2014: 53 · 2013: 47 · 2012: 53
FWCI
45.54
Type
journal article
Language
en
Open access
Licence
  • other-oa
  • journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Journal of Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
  • Max Planck Institute for Plasma Physics (submittedVersion)
  • ePrints Soton (University of Southampton) (submittedVersion)
  • Research Portal (King's College London) (submittedVersion)
  • Qucosa (Saxon State and University Library Dresden) (submittedVersion, other-oa)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
Keywords
anxiety disorders, pharmacotherapy, psychopharmacology, treatment guidelines, evidence-based recommendations, acute treatment, relapse prevention, treatment-resistant anxiety, clinical decision-making
MeSH terms
Adolescent, Adult, Aged, Antidepressive Agents, Anxiety Disorders, Behavior Therapy, Breast Feeding, Child, Preschool, Combined Modality Therapy, Female, Humans, Male, Middle Aged, Pregnancy, Psychotropic Drugs, Anti-Anxiety Agents, Treatment Outcome, Evidence-Based Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. https://app.cochat.ai/papers/10.1177/0269881105059253
The paper
Baldwin, D. S., Anderson, I. M., Nutt, D. J., Bandelow, B., Bond, A., Davidson, J. R. T., den Boer, J. A., Fineberg, N. A., Knapp, M., Scott, J., & Wittchen, H. U. (2005). Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology. https://doi.org/10.1177/0269881105059253

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.